Cleo Diagnostics (ASX:COV) Price-to-Tangible-Book : 2.22 (As of May. 11, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Price-to-Tangible-Book?

As of today (2024-05-11), Cleo Diagnostics's share price is A$0.175. Cleo Diagnostics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.08. Hence, Cleo Diagnostics's Price to Tangible Book Ratio of today is 2.22.

The historical rank and industry rank for Cleo Diagnostics's Price-to-Tangible-Book or its related term are showing as below:

ASX:COV' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.06 Med: 2.28 Max: 2.28
Current: 2.19

During the past 1 years, Cleo Diagnostics's highest Price to Tangible Book Ratio was 2.28. The lowest was 2.06. And the median was 2.28.

ASX:COV's Price-to-Tangible-Book is ranked better than
58.11% of 697 companies
in the Medical Devices & Instruments industry
Industry Median: 2.77 vs ASX:COV: 2.19

A closely related ratio is called PB Ratio. As of today, Cleo Diagnostics's share price is A$0.175. Cleo Diagnostics's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.08. Hence, Cleo Diagnostics's P/B Ratio of today is 2.13.

Cleo Diagnostics Price-to-Tangible-Book Historical Data

The historical data trend for Cleo Diagnostics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Price-to-Tangible-Book Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Price-to-Tangible-Book

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Price-to-Tangible-Book	-	-	2.28

Competitive Comparison of Cleo Diagnostics's Price-to-Tangible-Book

For the Medical Devices subindustry, Cleo Diagnostics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Price-to-Tangible-Book falls into.

Cleo Diagnostics Price-to-Tangible-Book Calculation

Cleo Diagnostics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.175	/	0.079
	=	2.22

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Cleo Diagnostics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines